Seeking Alpha

kingry's  Instablog

kingry
Send Message
I graduated in 2011 with degrees in accounting and finance. I worked briefly in the accounting industry (Big 4) and now currently work as an energy analyst in Houston. I am active in learning about different trading strategies. My current goals are to develop my own methodology and learn more... More
  • Biozone And Cocrystal - We Have Seen Something Like This Before 6 comments
    Dec 24, 2013 1:12 AM | about stocks: COCP, OPK, TRXC

    Thesis

    As stated in a letter of intent dated November 27th 2013, Biozone (BZNE) is to merge with privately held biotechnology company Cocrystal. Under the terms of the merger, Biozone will own 40% of the resulting company. Should the deal go through, Biozone's market value will increase to 40% of Cocrystal's implied value (more on this later), or $78.24 million, and result in a share price of $1.03. This represents an upside of 95% given Biozone's December 19th closing share price of 53 cents. I expect the merger to close by the end of the year.

    Background

    The companies mentioned have, directly or indirectly, been associated with Dr. Frost or his affiliates. According to Biozone's most recent 10-k, Opko Health (NYSE:OPK) and Frost Gamma Investments have significant holdings.

    Controversy regarding Biozone started mid-November when Musclepharm acquired substantially all of Biozone's assets in exchange for 1,200,000 shares of Musclepharm. Price action was hectic and shares plummeted. On November 27th, the letter of intent was issued explaining Biozone's commitment to merge with Cocrystal. It should be noted the 27th of November is exactly four weeks from the 25th of December.

    Upside

    The valuation stated in the thesis is based on a Cocrystal press release from 2011. In 2011, Cocrystal received an initial investment of $7.5 million from Teva Pharmaceutical with an option to invest $45 million. The language of the release indicates the maximum investment amount would entitle Teva to 23% of Cocrystal. This implies at that time Cocrystal was worth approximately $195.7 million. Assuming Cocrystal value has flat lined or increased, Biozone's resulting share price from the merger provides an attractive opportunity.

    Downside

    Simply put, if the merger does not occur, the share price will reflect an empty shell of a company. Biozone will be left with no assets and fall to a share price of .15-.25 cents (roughly the value of the Musclepharm consideration plus cash).

    Risks

    As explained in the downside portion, one risk is that the merger does not go through. The second risk regards the value of Cocrystal. I acknowledge that my valuation is based on a press release from 2011. Since then, Cocrystal could have become a billion dollar company or a shadow of its former self.

    Conclusion

    This particular situation offers an attractive upside. However, the downsides and risks should not be ignored. An important point to take note of is that we are dealing with Dr. Frost. By his own right, he is an accomplished investor. The process Biozone is going through has been seen before, and Dr. Frost is no stranger to it. Over the summer, SafeStitch Medical announced it would merge with private company TransEnterix. Under the merger agreement, SafeStitch would own 35% of the combined company and trade under the SafeStitch ticker initially. TransEnterix, like Cocrystal, was a private company. SafeStitch, like Biozone, counted Dr. Frost as one of its investors. Before the merger, SafeStitch traded just under $1 per share. Today, the combined company has a share price of about $1.70 (OTCQB:TRXC). Biozone aims to repeat history.

    The last point I will make regards Dr. Frost again. His holdings are at risk here as much as yours or mine. His motives are aligned with shareholders. It would be in his best interest to make this merger work and create value.

    Disclosure: I am long BZNE.

    Stocks: COCP, OPK, TRXC
Back To kingry's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (6)
Track new comments
  • kingry
    , contributor
    Comments (43) | Send Message
     
    Author’s reply » This is my first contribution to Seeking Alpha. Please provide any feedback or constructive criticism through a comment or PM.

     

    One comment I have already received is a margin of safety issue. The biggest weakness here, other than the deal falling through, is it may be difficult to find an acceptable entry point if you think there is upside.

     

    Thanks.
    24 Dec 2013, 01:22 AM Reply Like
  • dindin21
    , contributor
    Comments (45) | Send Message
     
    Good article. This is basically how I went about my analysis as well. A question I asked myself is what benefit does Biozone bring to Cocrystal? The only thing I can think of is it was an easier way for Cocrystal to go public.
    24 Dec 2013, 08:35 AM Reply Like
  • kingry
    , contributor
    Comments (43) | Send Message
     
    Author’s reply » I agree. The Safestich/TranEnterix deal used the reverse triangular merger method to bring TransEnterix public. Basically, SafeStich was used as a vehicle and then liquidated post merger (hence why there is no SFES ticker).

     

    I anticipate the same with happen to BZNE. Note in the press release language that the combined company will trade under the ticker BZNE "initially". See the link below in the last paragraph. The ticker will likely change to reference Cocrystal and the company name will likely change to Cocrystal.

     

    http://on.mktw.net/1eC...
    24 Dec 2013, 10:03 AM Reply Like
  • kingry
    , contributor
    Comments (43) | Send Message
     
    Author’s reply » I anticipate financials this week.
    8 Jan, 10:37 AM Reply Like
  • dindin21
    , contributor
    Comments (45) | Send Message
     
    Why do you expect this week?
    9 Jan, 10:28 AM Reply Like
  • kingry
    , contributor
    Comments (43) | Send Message
     
    Author’s reply » The 8k needs to be filed shortly after the close of the deal. I was expecting the filing last night to have Cocrystal financial statements. It did not. I am not sure at this point when we will get that. Does anyone have any thoughts on when we might see financials?

     

    One point in my thesis that is definitely inaccurate is my share count. I think we are going to see some dilution. I still think there is upside.
    9 Jan, 12:03 PM Reply Like
Full index of posts »
Latest Followers

StockTalks

  • Why is $RCPT up on news that dilution is coming? I have typically observed the opposite in similar cases. Can someone clarify?
    Jun 18, 2014
  • $BTX up big after hours, anyone know why?
    May 2, 2014
  • $CRDS Form 4!
    May 1, 2014
More »

Latest Comments


Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.